back
13 Jan 2022

DPI Impact and ESG

Related articles

DPI, BII and EBRD announce exit from KELIX bio, a leading emerging markets biopharmaceutical platform they created in 2020
| 25 Mar 2024
Principles of Responsible Investment 2023 Assessment
| 12 Feb 2024
Reflections on 2023 and a look ahead to 2024
| 20 Dec 2023
See all news
Copyright © DPI 2024